Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronomodulated vs Fixed Infusion FOLFOX in Metastatic Colorectal Cancer
NCT00003287Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 1998
- Primary completion
- Mar 2002
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 3 trial of fluorouracil, folinic acid, oxaliplatin in colorectal cancer (CRC), sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 1998; status: completed.
02
Drugs
fluorouracilfolinic acidoxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00003287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003287.